A randomised controlled trial comparing duloxetine and acetyl L-carnitine in fibromyalgic patients: preliminary data.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Fibromyalgia syndrome (FMS) is a chronic disorder characterised by widespread musculoskeletal pain, troubled sleep, disturbed mood, and fatigue. Recently published reviews have demonstrated that it is influenced by various psychological aspects, and antidepressants are now considered the treatment of choice for most patients. The aim of this randomised controlled trial was to compare the effects of duloxetine and acetyl L-carnitine on pain, depression, anxiety and well-being in FMS patients.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Clin. Exp. Rheumatol.

Title: Clinical and experimental rheumatology

ISSN: 0392-856X

ISSN (Print): 0392-856X

Publication date (Electronic): March 19 2015

Volume: 33

Issue: 1 Suppl 88

Affiliations

[1 ] Rita Levi Montalcini Department of Neuroscience, University of Turin, Turin, Italy.

[2 ] Department of Psychology, University of Turin, Turin, Italy.

[3 ] Rheumatology Department, Azienda Ospedaliera Città della Salute e della Scienza di Torino, Turin, Italy.

[4 ] Rheumatology Unit, L. Sacco University Hospital, Milan, Italy.

[5 ] IRCCS Galeazzi Orthopaedic Institute, Milan, Italy.

Article

Publisher Item ID: 9184

PubMed ID: 25786048

SO-VID: fcbd152d-1eff-4f30-af13-4c30caf48450

History

Data availability:

Comments

Comment on this article

Cited by 9

See all cited by